Physician

Farshad Raissi Shabari, M.D., M.P.H.

According to 2025 Medicare claims, Farshad Shabari, M.D., M.P.H. (NPI: 1124295027) practices cardiac electrophysiology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is IMPERIAL VALLEY FAMILY CARE MEDICAL GROUP APC (NPI: 1275581894; TIN: 330652678) and primary practice location at 92251-9805. Shabari is affiliated with the Aledade 60 CA MSSP Enhanced (ACO ID: A4775), participating under the MSSP model.

Shabari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 737 traditional Medicare patients, billed 1,766 HCPCS/CPT codes, and received $254,964 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,179 prescription claims across 235 beneficiaries totaling $343,594 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 17 claims. Open Payments data shows 107 records totaling $25,163. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $51,096 to $254,964. Similarly, Part D prescription costs have risen steadily, from $29,488 to $343,594. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	208	561	$51,096
2016	448	1,133	$80,126
2017	1,198	3,085	$181,796
2018	1,139	2,977	$166,423
2019	862	1,957	$130,131
2020	1,068	2,704	$165,546
2021	944	2,390	$173,663
2022	923	2,215	$202,059
2023	852	1,930	$232,299
2024	737	1,766	$254,964

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	58	239	$29,488
2016	135	388	$26,316
2017	237	1,013	$71,868
2018	258	1,125	$140,658
2019	168	526	$85,551
2020	222	909	$133,596
2021	219	760	$134,695
2022	241	1,093	$234,792
2023	275	1,338	$378,853
2024	235	1,179	$343,594

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	17	$31,665
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	129	158	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	96	114	$67
93248	Heart rhythm review and interpretation of continous external ekg over 8-15 days	199	202	$20
93228	Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional	69	70	$20
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	78	102	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	216	9,330	$176,432
Multaq	Dronedarone Hcl	65	2,640	$69,573
Xarelto	Rivaroxaban	47	2,700	$48,636
Entresto	Sacubitril/Valsartan	24	780	$17,121
Jardiance	Empagliflozin	19	570	$11,060

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	107	$25,163	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Farshad Raissi Shabari, M.D., M.P.H.?

Tedicare shows public-source Medicare data for Farshad Raissi Shabari, M.D., M.P.H. (NPI 1124295027), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Farshad Raissi Shabari, M.D., M.P.H. have ACO affiliation data?

Farshad Raissi Shabari, M.D., M.P.H. is shown with ACO affiliation data for Aledade 60 CA MSSP Enhanced (MSSP, ACO ID A4775).

What billing organization is linked to Farshad Raissi Shabari, M.D., M.P.H.?

Farshad Raissi Shabari, M.D., M.P.H. is linked to IMPERIAL VALLEY FAMILY CARE MEDICAL GROUP APC (billing NPI 1275581894) in the available physician profile data.

Does Farshad Raissi Shabari, M.D., M.P.H. have Open Payments data?

Farshad Raissi Shabari, M.D., M.P.H. has 107 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.